ISS P-002 HIV vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISS P-002 HIV vaccine, covering 2016-03-04 to 2016-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002) [Phase 1]